Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


18.03.2019

1 Br J Cancer
1 Br J Neurosurg
5 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
16 J Neurooncol
1 J Neuropathol Exp Neurol
2 J Neurosurg
2 J Nucl Med
3 Neuro Oncol
1 Neurosurgery
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Cancer

  1. KAMIL M, Shinsato Y, Higa N, Hirano T, et al
    High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.
    Br J Cancer. 2019 Mar 14. pii: 10.1038/s41416-019-0413.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  2. BUNYARATAVEJ K, Wangsawatwong P
    Catheter guided cerebral glioma resection combined with awake craniotomy: its usefulness and surgical outcome.
    Br J Neurosurg. 2019 Mar 12:1-8. doi: 10.1080/02688697.2019.1587380.
    PubMed     Text format     Abstract available


    Cancer Res

  3. SIMONE L, Pisani F, Mola MG, De Bellis M, et al
    AQP4 aggregation state is a determinant for glioma cell fate.
    Cancer Res. 2019 Mar 15. pii: 0008-5472.CAN-18-2015.
    PubMed     Text format     Abstract available

  4. HOFFMAN M, Gillmor A, Kunz DJ, Johnston MJ, et al
    Intratumoral genetic and functional heterogeneity in pediatric glioblastoma.
    Cancer Res. 2019 Mar 15. pii: 0008-5472.CAN-18-3441.
    PubMed     Text format     Abstract available

  5. XIAO W, Zhang R, Sohrabi A, Ehsanipour A, et al
    Correction: Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
    Cancer Res. 2019;79:1260.
    PubMed     Text format    

  6. LATHIA JD
    Drak, Drak, Goose: A New Signaling Axis in Glioblastoma.
    Cancer Res. 2019;79:1036-1037.
    PubMed     Text format     Abstract available

  7. TAO R, Murad N, Xu Z, Zhang P, et al
    MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-1787.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  8. LI H, Li J, Chen L, Qi S, et al
    HERC3-mediated SMAD7 ubiquitination degradation promotes autophagy-induced EMT and chemoresistance in glioblastoma.
    Clin Cancer Res. 2019 Mar 12. pii: 1078-0432.CCR-18-3791.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. MUELLER S, Jain P, Liang WS, Kilburn L, et al
    A pilot precision medicine trial for children with diffuse intrinsic pontine glioma - PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32258.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  10. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
    Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. FREEDMAN RA, Gelman RS, Anders CK, Melisko ME, et al
    TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
    J Clin Oncol. 2019 Mar 12:JCO1801511. doi: 10.1200/JCO.18.01511.
    PubMed     Text format     Abstract available


    J Neurooncol

  12. OGAWA Y, Jokura H, Niizuma K, Tominaga T, et al
    Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?
    J Neurooncol. 2018;137:543-549.
    PubMed     Text format     Abstract available

  13. JEON SH, Park SH, Kim JW, Park CK, et al
    Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.
    J Neurooncol. 2018;137:567-573.
    PubMed     Text format     Abstract available

  14. BARANISKIN A, Chomiak M, Ahle G, Gress T, et al
    MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    J Neurooncol. 2018;137:463-468.
    PubMed     Text format     Abstract available

  15. FILLEY A, Henriquez M, Bhowmik T, Tewari BN, et al
    Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas.
    J Neurooncol. 2018;137:469-479.
    PubMed     Text format     Abstract available

  16. KIMURA A, Takemura M, Serrero G, Yoshikura N, et al
    Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
    J Neurooncol. 2018;137:455-462.
    PubMed     Text format     Abstract available

  17. SALA E, Moore JM, Amorin A, Martinez H Jr, et al
    CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience.
    J Neurooncol. 2018;138:291-298.
    PubMed     Text format     Abstract available

  18. FORSTER N, Warnick R, Takiar V, Pater L, et al
    Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery.
    J Neurooncol. 2018;138:335-340.
    PubMed     Text format     Abstract available

  19. DE B, Khakoo Y, Souweidane MM, Dunkel IJ, et al
    Patterns of relapse for children with localized intracranial ependymoma.
    J Neurooncol. 2018;138:435-445.
    PubMed     Text format     Abstract available

  20. SANTOS VM, Marta GN, Mesquita MC, Lopez RVM, et al
    The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma.
    J Neurooncol. 2019 Mar 8. pii: 10.1007/s11060-019-03137.
    PubMed     Text format     Abstract available

  21. SMITH DR, Bian Y, Wu CC, Saraf A, et al
    Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases.
    J Neurooncol. 2019 Mar 14. pii: 10.1007/s11060-019-03149.
    PubMed     Text format     Abstract available

  22. SHAHIN MN, Magill ST, Dalle Ore CL, Viner JA, et al
    Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.
    J Neurooncol. 2019 Mar 13. pii: 10.1007/s11060-019-03147.
    PubMed     Text format     Abstract available

  23. HUI CY, Rudra S, Ma S, Campian JL, et al
    Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients.
    J Neurooncol. 2019 Mar 12. pii: 10.1007/s11060-019-03146.
    PubMed     Text format     Abstract available

  24. SCHRECK KC, Ranjan S, Skorupan N, Bettegowda C, et al
    Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
    J Neurooncol. 2019 Mar 12. pii: 10.1007/s11060-019-03134.
    PubMed     Text format     Abstract available

  25. RIJNEN SJM, Sitskoorn MM, Gehring K
    Comment on: Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes.
    J Neurooncol. 2019 Mar 12. pii: 10.1007/s11060-019-03148.
    PubMed     Text format    

  26. COMPES P, Tabouret E, Etcheverry A, Colin C, et al
    Correction to: Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016.
    J Neurooncol. 2019 Mar 11. pii: 10.1007/s11060-019-03141.
    PubMed     Text format     Abstract available

  27. DEWEYERT A, Iredale E, Xu H, Wong E, et al
    Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
    J Neurooncol. 2019 Mar 9. pii: 10.1007/s11060-019-03145.
    PubMed     Text format     Abstract available


    J Neuropathol Exp Neurol

  28. LI M, Zeng L, Liu S, Dangelmajer S, et al
    Transforming Growth Factor-beta Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Mar 12. pii: 5376675. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurosurg

  29. WANG W, Swenson S, Cho HY, Hofman FM, et al
    Efficient brain targeting and therapeutic intracranial activity of bortezomib through intranasal co-delivery with NEO100 in rodent glioblastoma models.
    J Neurosurg. 2019 Mar 15:1-9. doi: 10.3171/2018.11.JNS181161.
    PubMed     Text format     Abstract available

  30. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas in the precentral gyrus: utility for predicting motor function.
    J Neurosurg. 2019 Mar 15:1-11. doi: 10.3171/2018.11.JNS182609.
    PubMed     Text format     Abstract available


    J Nucl Med

  31. GEISLER S, Stegmayr C, Niemietz N, Lohmann P, et al
    Treatment-related uptake of O-(2-[(18)F]fluoroethyl)-L-tyrosine and L-[methyl-(3)H]-methionine after tumor resection in rat glioma models.
    J Nucl Med. 2019 Mar 8. pii: jnumed.119.225680. doi: 10.2967/jnumed.119.225680.
    PubMed     Text format     Abstract available

  32. WANG H, Hou B, Lu L, Feng M, et al
    PET/MR imaging in the diagnosis of hormone-producing pituitary micro-adenoma: a prospective pilot study.
    J Nucl Med. 2017 Aug 3. pii: jnumed.117.191916. doi: 10.2967/jnumed.117.191916.
    PubMed     Text format     Abstract available


    Neuro Oncol

  33. ICHIMURA K
    TERT promoter mutation as a diagnostic marker for diffuse gliomas.
    Neuro Oncol. 2019 Mar 10. pii: 5372924. doi: 10.1093.
    PubMed     Text format    

  34. SAIT SF, Karajannis MA
    The new kid on the block: suicide gene therapy to modulate cancer immunosurveillance for children with high-risk malignant brain tumors.
    Neuro Oncol. 2019 Mar 10. pii: 5372925. doi: 10.1093.
    PubMed     Text format    

  35. AKAMANDISA MP, Nie K, Nahta R, Hambardzumyan D, et al
    Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
    Neuro Oncol. 2019 Mar 10. pii: 5372846. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  36. KARSY M, Jensen MR, Guan J, Ravindra VM, et al
    EQ-5D Quality-of-Life Analysis and Cost-Effectiveness After Skull Base Meningioma Resection.
    Neurosurgery. 2019 Mar 14. pii: 5380585. doi: 10.1093.
    PubMed     Text format     Abstract available


    PLoS One

  37. RICHTIG G, Hoeller C, Wolf M, Wolf I, et al
    Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
    PLoS One. 2018;13:e0204729.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  38. ZHANG Y, Li J, Yi K, Feng J, et al
    Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma.
    Proc Natl Acad Sci U S A. 2019 Mar 15. pii: 1814060116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: